Wednesday, February 10, 2010, 6:42am EST - Canadian Markets open in 2 hours and 48 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Rydex Biotechnology Inv (RYOIX)

On Feb 9: 25.25 USD  Up 0.26 (1.04%)  
MORE ON RYOIX
Quotes
HereSummary
Charts
News & Info
Fund
Analyst
RYDEX SERIES TRST BIOTECHNOLOGY Delayed quote dataEdit
Net Asset Value: 25.25
Trade Time: Feb 9
Change: Up 0.26 (1.04%)
Prev Close: 25.25
YTD Return*: 5.69%
Net Assets*: 59.68M
Yield*: N/A
* As of 31-Dec-07
Rydex Biotechnology Inv (RYOIX)
3m  6m  1y  2y  5y  max 
 Add RYOIX to Portfolio   Download Data

HEADLINES
Top Health Equity Funds
Zacks.com (Fri, Jul 10)
More Headlines for RYOIX...

31-Dec-07
FUND BASICS
Morningstar Overall Rating: 2 stars
Total Assets: 59.68M
Category: Specialty-Health
Total Expense Ratio: 1.37%
Fund Profile - Holdings


31-Dec-07
PERFORMANCE & RISK
YTD Return: 5.69%
5y Avg Return: 11.29%
Rank in Category (ytd): 124
% Rank in Category (ytd): 61.69%
Beta (3y): 1.18
Morningstar Risk Rating: High
Performance Details - Risk Details

FUND SUMMARY
The investment seeks capital appreciation. The fund primarily invests in equity securities issued by biotechnology companies that are traded in the United States, as well as in futures and options contracts. Biotechnology companies include those engaged in the research, development, and manufacture of various biotechnological and biomedical products. It is nondiversified.
Fund Profile


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices